Abstract
Since its initial use in treating TBAD was reported in 1999, thoracic endovascular aortic repair (TEVAR) has evolved as the treatment of choice for complicated descending thoracic aortic dissections [1-6].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Biomedical Journal of Scientific & Technical Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.